1. Home
  2. LEE vs RNA Comparison

LEE vs RNA Comparison

Compare LEE & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lee Enterprises Incorporated

LEE

Lee Enterprises Incorporated

HOLD

Current Price

$9.23

Market Cap

209.0M

ML Signal

HOLD

Logo Avidity Biosciences Inc.

RNA

Avidity Biosciences Inc.

HOLD

Current Price

$12.61

Market Cap

211.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LEE
RNA
Founded
1890
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Newspapers/Magazines
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
209.0M
211.6M
IPO Year
2025
2025

Fundamental Metrics

Financial Performance
Metric
LEE
RNA
Price
$9.23
$12.61
Analyst Decision
Buy
Analyst Count
0
20
Target Price
N/A
$69.26
AVG Volume (30 Days)
68.2K
177.9K
Earning Date
05-07-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$543,955,000.00
N/A
Revenue This Year
$5.48
$88.12
Revenue Next Year
N/A
$18.11
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.34
$11.40
52 Week High
$11.88
$73.06

Technical Indicators

Market Signals
Indicator
LEE
RNA
Relative Strength Index (RSI) 41.24 47.91
Support Level $7.95 $12.56
Resistance Level $9.44 $14.05
Average True Range (ATR) 0.79 0.48
MACD -0.24 0.15
Stochastic Oscillator 8.62 80.09

Price Performance

Historical Comparison
LEE
RNA

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.

About RNA Avidity Biosciences Inc.

Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.

Share on Social Networks: